≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Deep bite that required surgery

Endpoint Browser PheWeb

K11_DEEP_BITE_SURGERY

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • OPER_BSSRO
1338

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — K07.23
  • Cause of death: ICD-10 — K07.23

2 out of 7 registries used, show all original rules.

464

4. Check minimum number of events

None

464

5. Include endpoints

None

464

6. Filter based on genotype QC (FinnGen only)

464

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2875 1851 1018
Only index persons 2854 1841 1013
Unadjusted period prevalence (%)
Whole population 0.04 0.05 0.03
Only index persons 0.06 0.07 0.04
Median age at first event (years)
Whole population 37.45 37.25 37.86
Only index persons 37.48 37.25 37.91

-FinnGen-

Key figures

All Female Male
Number of individuals 464 321 143
Unadjusted period prevalence (%) 0.10 0.11 0.06
Median age at first event (years) 39.58 38.87 41.16

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
408
Matched controls
4079
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K07.13
ICD-10 Finland
Retrognaty, mandibular
1961.3
323.0
356
14
SJD00
NOMESCO Finland
Removal or reattacment of arrow in fixed orthodontisk device
434.5
323.0
322
35
EDC10
NOMESCO Finland
Sagittal osteotomy of ramus of mandible
+∞
323.0
408
6
SJD10
NOMESCO Finland
Attachment of arrow to fixed orthodontisk device
342.2
323.0
298
32
K07.23
ICD-10 Finland
Deep bite
+∞
323.0
408
33
SBB10
NOMESCO Finland
Teeth copy
142.2
320.9
341
140
SJD20
NOMESCO Finland
Attachment of modifiable arrow of fixed orthodontisk device
289.1
307.2
284
32
SJC10
NOMESCO Finland
Orthodontic bandage in one tooth
402.4
296.1
267
19
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
145.1
281.4
284
63
SJC50
NOMESCO Finland
Removal of orthodontisk device with at least 7 brackets
221.7
272.7
260
32
SJB00
NOMESCO Finland
Fitting of loose orthodontic device with user information
200.3
252.5
244
30
SJD30
NOMESCO Finland
Demanding attachment of arrow to fixed orthodontisk device
276.2
225.5
213
16
EB1MA
NOMESCO Finland
Cephalometry with X-ray
110.5
217.9
228
46
SJX10
NOMESCO Finland
Short check-up visit for orthodontisk therapy
100.7
201.6
214
44
SJC03
NOMESCO Finland
Positioning and fixed attachment of brackets, extensive
160.9
195.3
195
23
SJD40
NOMESCO Finland
Fixation of ready made palatinal or lingual arrow
104.7
178.0
188
33
SJC01
NOMESCO Finland
Positioning and fixed attachment of single bracket (Bracket with fixed attachment)
129.0
176.1
181
25
SAA04
NOMESCO Finland
Special inverstigation of mouth
34.3
145.2
196
107
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
37.6
140.8
184
87
SJC02
NOMESCO Finland
Positioning and fixed attachment of brackets
172.4
129.1
130
11
SJC40
NOMESCO Finland
Removal of orthodontisk device with at most 6 brackets
95.3
125.4
135
21
SXC05
NOMESCO Finland
Other oral or dental procedure
23.1
116.4
178
132
SJB60
NOMESCO Finland
External device grinding and adaptation
115.0
110.1
116
14
SJX11
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment, restricted
64.4
110.0
126
28
K07.20
ICD-10 Finland
Crossbite (anterior)(posterior)
178.2
104.9
106
8
SJX20
NOMESCO Finland
Check-up visit for orthodontisk therapy
65.9
103.4
118
25
SJX21
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment
82.1
98.9
109
18
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
12.0
96.5
209
329
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
22.6
93.4
141
93
SJC00
NOMESCO Finland
Bracket with fixed attachment
220.2
87.0
87
5
SAC03
NOMESCO Finland
Separate planning of oral and dental treatment, very demanding
207.5
82.6
83
5
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
14.8
69.7
124
117
K07.22
ICD-10 Finland
Anomalies of dental arch relationship
168.3
68.3
70
5
EBB10
NOMESCO Finland
Insertion of dental implant
51.9
67.2
80
19
SAA03
NOMESCO Finland
Extended examination of mouth
6.4
64.3
300
1236
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
27.3
62.6
87
40
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
9.4
55.8
127
187
EEC05
NOMESCO Finland
Le Fort I osteotomy
317.3
55.7
55
*
SAC02
NOMESCO Finland
Separate planning of oral and dental treatment, demanding
55.0
55.2
65
14
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.4
54.8
248
913
SJA04
NOMESCO Finland
Very demanding plan for orthodontic care
110.1
53.4
57
6
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
158.4
53.3
55
*
SAC01
NOMESCO Finland
Separate planning of oral and dental treatment, standard
54.9
51.8
61
13
SJD50
NOMESCO Finland
Production and attachment of palatinal or lingual arrow
198.0
51.2
52
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
5.0
50.6
277
1209
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
101.3
49.1
53
6
K07.60
ICD-10 Finland
Snapping jaw
9.8
48.8
106
141
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
15.8
47.6
80
62
SJF01
NOMESCO Finland
Assessment of need for orthodontic treatment
44.8
47.4
58
15
SJB10
NOMESCO Finland
Fitting of loose orthodontic device with user information, demanding
59.3
44.8
52
10
EBB15
NOMESCO Finland
Insertion of dental implant abutment
40.5
40.1
50
14
K07.04
ICD-10 Finland
Macrognathism (mandibular)(maxillary)
414.2
38.7
38
*
K07.24
ICD-10 Finland
Open bite
26.3
38.2
53
23
K07.10
ICD-10 Finland
Asymmetry of jaw
91.0
37.6
41
5
K07.27
ICD-10 Finland
Anomalies of dental arch relationship
54.6
37.4
44
9
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
7.8
36.9
91
144
K07.14
ICD-10 Finland
Retrognaty, maxillary
107.5
36.4
39
*
SJA01
NOMESCO Finland
Estimation of need for orthodontic care
349.7
32.3
32
*
SJA03
NOMESCO Finland
Demanding plan for orthodontic care
63.5
30.6
35
6
SXC03
NOMESCO Finland
Other oral or dental procedure
27.6
29.4
40
16
SJX00
NOMESCO Finland
Reparation of orthodontiskt device by dentist
71.5
29.4
33
5
EBA10
NOMESCO Finland
Surgical removal of tooth
4.5
29.3
121
351
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
16.3
27.2
44
30
K00.00
ICD-10 Finland
Hypodontia
20.4
26.2
39
21
SJA02
NOMESCO Finland
Plan for orthodontic care
144.1
25.9
27
*
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
41.7
25.3
31
8
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
11.1
23.5
45
45
K07.12
ICD-10 Finland
Prognathism (mandibular)(maxillary)
+∞
23.1
22
*
J01CE02
ATC
phenoxymethylpenicillin; oral
3.6
23.0
346
2489
SJE90
NOMESCO Finland
Finishing face of orthodontick therapy
66.3
22.1
25
*
K07.1
ICD-10 Finland
Anomalies of jaw-cranial base relationship
66.3
22.1
25
*
K07.18
ICD-10 Finland
Another anomaly in the relationship between jaw and skull base
121.5
21.8
23
*
EB1WA
NOMESCO Finland
NA
33.3
21.8
28
9
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
15.2
21.2
35
25
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
63.5
21.1
24
*
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
8.2
19.5
44
59
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
29.5
18.9
25
9
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
15.1
18.9
31
22
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
46.3
18.4
22
5
K01.0
ICD-10 Finland
Embedded teeth
10.0
18.0
36
39
EBA12
NOMESCO Finland
Complicated surgical removal of tooth
7.2
18.0
44
67
ZXA10
NOMESCO Finland
Bilateral
3.5
17.4
93
321
SPB10
NOMESCO Finland
Production of temporary crone to tooth
23.1
17.1
24
11
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
16.5
139
649
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
3.3
16.1
89
315
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
13.7
15.9
27
21
SAA02
NOMESCO Finland
Basic examination of mouth
2.6
15.4
319
2368
Z96.5
ICD-10 Finland
Presence of tooth-root and mandibular implants
29.9
15.3
20
7
SPA41
NOMESCO Finland
Precision impression for fixed dental prosthesis
14.1
14.4
24
18
OIKK
NOMESCO Finland
NA
11.5
14.2
26
24
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
18.4
14.0
21
12
K07.19
ICD-10 Finland
Anomalies in the relationship between jaw and skull base UNS
144.6
13.5
14
*
SDA02
NOMESCO Finland
Parodonthologic therapy
2.2
11.9
164
958
K07.11
ICD-10 Finland
Retrognathism (mandibular)(maxillary)
31.0
11.7
15
5
EDC30
NOMESCO Finland
Genioplasty
36.1
11.3
14
*
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
10.0
10.9
21
22
SAA01
NOMESCO Finland
Simple examination of mouth
2.3
10.8
329
2638
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.4
10.6
38
93
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
2.2
10.4
134
747
SPC40
NOMESCO Finland
Preparation of first or second intermediate attachment tooth for bridge
24.1
10.3
14
6
SPB20
NOMESCO Finland
Temporary bridge between two or more teeth
24.1
10.3
14
6
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
15.1
10.1
16
11
K01.17
ICD-10 Finland
Retained molar with obstruction in the lower jaw
5.6
9.9
28
53
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
4.4
9.8
35
85
SPA02
NOMESCO Finland
Preparation for dental prosthetics
9.0
9.4
19
22
R06.5
ICD-10 Finland
Mouth breathing
3.3
9.1
46
151
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
2.1
9.1
130
750
SPC25
NOMESCO Finland
Other demanding attachment of crone of tooth
37.6
9.1
11
*
SPC08
NOMESCO Finland
Implant crown
24.6
9.0
12
5
EG1CG
NOMESCO Finland
Extensive MRI examination of mandipular joint with high intensity magnet
20.5
8.5
12
6
ECU00
NOMESCO Finland
Removal of implant or external fixation device from alveoli
+∞
8.4
8
*
N02BE01
ATC
paracetamol; systemic, rectal
2.1
8.2
342
2885
EB1AD
NOMESCO Finland
Cone beam CT of teeth and jaws (one quarter)
17.6
8.1
12
7
EBA00
NOMESCO Finland
Extraction of tooth
1.9
7.9
144
906
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.9
7.8
143
902
ECB05
NOMESCO Finland
Mucogingival repair
45.9
7.7
9
*
SPC09
NOMESCO Finland
Implant crown, demanding
45.9
7.7
9
*
SPAT1324
SPAT
Screening procedure
2.0
7.7
112
646
K07.9
ICD-10 Finland
Dentofacial anomaly, unspecified
81.5
7.4
8
*
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.8
7.2
172
1178
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
8.1
7.2
15
19
M01AE01
ATC
ibuprofen; systemic, rectal
2.7
6.8
384
3484
G50.8
ICD-10 Finland
Other disorders of trigeminal nerve
40.7
6.8
8
*
K07.26
ICD-10 Finland
Anomalies of dental arch relationship
40.7
6.8
8
*
EAB10
NOMESCO Finland
Excision and repair of frenum of lip
40.7
6.8
8
*
EMAK
NOMESCO Finland
NA
3.8
6.7
27
75
EDW99
NOMESCO Finland
Other operation on mandible
22.9
6.7
9
*
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
10.3
6.6
12
12
ECA30
NOMESCO Finland
Excision of lesion of gingiva
10.3
6.6
12
12
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
6.5
189
1363
TEG00
NOMESCO Finland
Punction of mandibular joint
70.9
6.4
7
*
K07.33
ICD-10 Finland
Crowding of tooth or teeth
18.4
6.3
9
5
K07.05
ICD-10 Finland
Micrognatia (hypoplasia) of both jaws
+∞
6.3
6
*
K07.29
ICD-10 Finland
Anomaly in the relationship between the tooth arches UNS
+∞
6.3
6
*
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
27.1
6.2
8
*
EB1BD
NOMESCO Finland
Extensive cone beam CT of teeth and jaws (two quarters)
27.1
6.2
8
*
K06.00
ICD-10 Finland
Local gingivore traction
6.2
6.0
15
25

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
235
1738
1.71
7.45
3.4
4.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
198
1462
1.62
5.89
3.0
2.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
324
2751
1.59
4.91
3.5
3.6
mm/h
7.0
9.1
5.80
311
2602
(3029937) Albumin [Presence] in Urine by Test strip
133
964
1.53
3.99
3.3
3.1
estimate
0.0
0.0
1.08
41
359
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
41
217
1.98
3.82
1.4
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
115
824
1.53
3.60
3.4
3.0
kg/l
1.0
1.0
0.14
18
102
(40761511) CBC panel - Blood by Automated count
443
4201
2.20
3.26
9.9
9.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
44
253
1.82
3.22
3.1
3.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
19
83
2.34
2.88
1.0
1.1
u/ml
9.0
5.4
—
7
42
(3005322) IgE [Units/volume] in Serum or Plasma
47
286
1.72
2.86
1.2
1.3
u/ml
143.6
278.7
0.72
47
264
(4010399)
41
240
1.78
2.85
1.3
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
220
1850
1.36
2.72
4.0
4.1
estimate
0.0
0.0
0.50
40
362
(3021387) Prolactin [Units/volume] in Serum or Plasma
41
244
1.75
2.70
1.7
1.5
mu/l
352.9
285.9
0.38
36
218
(3035350) Ketones [Presence] in Urine by Test strip
219
1844
1.36
2.67
3.0
2.9
estimate
0.0
0.0
0.00
40
357
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
82
582
1.50
2.65
1.4
1.6
pmol/l
73684647.3
42395858.4
0.16
76
526
(3023103) Potassium [Moles/volume] in Serum or Plasma
410
3846
1.57
2.51
7.9
11.0
mmol/l
3.9
3.9
0.21
403
3736
(4198724)
9
26
3.51
2.49
2.0
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
407
3829
1.51
2.26
7.9
11.0
mmol/l
139.9
139.7
1.58
399
3733
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
138
1110
1.35
2.19
2.3
2.7
ng/l
14.0
20.5
1.02
65
553
(3009261) Glucose [Presence] in Urine by Test strip
217
1868
1.30
2.12
3.0
2.9
estimate
0.0
0.0
0.00
38
347
(3041096) Erythrocytes [Presence] in Urine by Automated
135
1093
1.33
2.04
2.3
2.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
116
920
1.35
2.01
1.5
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
15
70
2.18
2.00
1.3
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
18
91
2.02
1.98
1.1
1.1
u/ml
0.5
1.9
—
6
35
(3014133) Dog dander IgE Ab [Units/volume] in Serum
15
71
2.15
1.94
1.0
1.1
u/ml
11.9
3.2
—
8
22
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
53
370
1.49
1.88
4.5
5.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
17
87
1.99
1.82
1.8
1.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
32
490
0.63
1.79
2.0
3.4
mmol/l
0.9
0.8
2.34
27
464
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
412
3920
1.46
1.79
8.6
10.7
mg/l
17.1
20.0
0.81
318
2980
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
67
2.12
1.77
1.3
3.9
mg/l
19.9
18.5
—
8
45
(3023430) Cat dander IgE Ab [Units/volume] in Serum
13
61
2.16
1.73
1.0
1.1
u/ml
2.6
4.8
—
7
20
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
164
0.42
1.69
1.3
1.5
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
18
98
1.87
1.64
1.3
1.4
u/l
21.6
24.4
—
10
83
(3045424) Erythrocytes [Presence] in Urine
13
63
2.09
1.61
1.2
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
82
638
1.35
1.61
1.5
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
380
3585
1.33
1.59
4.5
4.6
mu/l
1.8
2.1
0.48
367
3420
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
74
946
0.74
1.58
1.7
1.7
mmol/l
1.5
1.4
0.21
67
841
(1002224) Polysomnography panel
13
245
0.52
1.57
1.1
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
32
209
1.57
1.56
1.3
1.4
miu/ml
237.9
255.0
0.10
15
110
(40758558) Short blood count panel - Blood
71
910
0.74
1.54
3.7
6.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
23
139
1.69
1.51
1.9
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
13
65
2.03
1.50
3.0
3.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
70
895
0.74
1.49
2.6
3.6
ph
7.4
7.4
0.18
12
161
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
32
212
1.55
1.48
2.2
1.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
22
2.75
1.44
1.0
1.1
miu/ml
1386.0
1807.7
—
6
22
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
71
551
1.34
1.42
3.4
3.2
%
20.0
22.1
0.42
23
184
(3023368) Bacteria identified in Blood by Culture
56
730
0.74
1.36
3.1
4.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
39
275
1.46
1.36
1.8
1.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
117
979
1.26
1.34
3.1
4.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
39
276
1.45
1.34
1.8
1.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
129
1.66
1.32
1.2
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
100
1198
0.79
1.30
4.6
5.8
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
18
2.80
1.29
1.0
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
384
3658
1.29
1.27
3.4
3.6
mmol/l
5.6
5.7
3.64
369
3448
(3010726) Horse dander IgE Ab [Units/volume] in Serum
14
77
1.84
1.26
1.0
1.1
u/ml
0.9
2.8
—
7
16
(3044889) 12 lead EKG panel
269
2468
1.21
1.26
2.7
2.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
38
271
1.44
1.26
2.6
2.2
u/l
8473.5
3305.6
0.41
19
119
(3000764) Benzodiazepines [Presence] in Urine
38
274
1.42
1.20
1.8
2.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
431
4181
1.43
1.19
7.9
8.8
u/l
27.6
27.8
0.07
422
4094
(3007853) Bacteria identified in Skin by Aerobe culture
54
414
1.34
1.19
1.4
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
38
275
1.42
1.18
1.8
1.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
39
2.07
1.16
1.8
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
102
855
1.25
1.15
1.6
1.7
mg/l
0.7
0.8
0.24
69
641
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
100
838
1.25
1.13
2.1
2.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
96
1136
0.80
1.11
1.6
1.8
pmol/l
103.4
97.2
0.67
50
598
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
81
1.75
1.10
1.5
1.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
27
383
0.69
1.10
1.4
2.3
%
23.4
24.8
0.17
22
334
(3000991) Gas panel - Venous blood
13
216
0.59
1.07
6.8
9.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
209
1896
1.19
1.05
3.3
4.6
mmol/l
6.0
6.4
3.04
189
1734
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
292
2729
1.19
1.02
5.2
7.1
u/l
70.6
75.0
1.94
280
2596
(3013139) Helicobacter pylori Ag [Presence] in Stool
36
266
1.38
1.01
1.2
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
34
455
0.73
1.00
1.7
2.3
e6/l
4.3
3.2
0.33
20
215
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
83
692
1.24
0.99
3.7
3.2
ug/l
1.5
1.5
0.14
77
642
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
387
3719
1.24
0.98
3.4
3.4
mmol/l
1.3
1.3
0.20
373
3542
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
29
0.00
0.98
0.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
47
365
1.32
0.97
1.3
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
53
419
1.30
0.97
2.8
2.3
ug/l
0.6
0.6
0.16
20
216
(4281824)
0
31
0.00
0.96
0.0
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
24
166
1.47
0.96
1.0
1.3
u/l
11.1
10.4
0.08
19
134
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
324
3066
1.19
0.94
4.3
4.1
pmol/l
14.4
14.4
0.11
312
2891
(3023323) Follitropin [Units/volume] in Serum or Plasma
43
332
1.33
0.93
1.2
1.3
iu/l
30.7
27.4
0.23
38
286
(3016879) Cocaine [Presence] in Urine
34
253
1.37
0.93
1.9
2.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
20
134
1.51
0.93
1.3
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
43
548
0.76
0.92
2.3
3.4
ng/l
351.5
503.3
0.16
22
347
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
101
0.49
0.90
1.0
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
22
311
0.69
0.90
2.4
3.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
71
589
1.24
0.89
1.6
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
125
1098
1.19
0.89
1.8
2.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
27
195
1.41
0.88
1.3
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
30
2.01
0.87
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
89
762
1.21
0.84
2.1
2.0
—
—
—
0
0
(4035726)
18
259
0.68
0.82
1.3
1.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
16
106
1.53
0.80
1.8
1.9
pmol/l
206.4
222.8
0.23
16
100
(3025941) Bacteria identified in Stool by Culture
32
244
1.33
0.78
1.2
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
27
0.00
0.77
0.0
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
27
0.00
0.77
0.0
1.7
—
—
—
0
0
(44813793)
6
34
1.77
0.76
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
67
1.66
0.75
1.4
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
122
1085
1.17
0.75
2.1
2.6
u/l
54.2
54.5
0.03
113
1024
(3013290) Carbon dioxide [Partial pressure] in Blood
9
54
1.68
0.75
1.0
2.7
kpa
4.9
5.1
—
9
54
(3027315) Oxygen [Partial pressure] in Blood
9
54
1.68
0.75
1.0
2.7
kpa
9.4
9.3
—
9
54
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
24
2.09
0.74
1.0
1.3
ug/l
5.0
7.2
—
5
18
(3035637) Corticotropin [Mass/volume] in Plasma
7
38
1.85
0.74
1.4
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
77
660
1.20
0.73
1.5
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
14
205
0.67
0.71
1.3
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
68
578
1.21
0.70
2.2
2.4
ug/g
65.7
109.6
1.62
56
463
(3002256) Pathology report gross observation
37
461
0.79
0.69
1.3
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
7
117
0.59
0.68
1.4
1.2
—
69.2
—
0
13
(1001926) Buprenorphine [Presence] in Urine by Screen method
28
214
1.33
0.68
2.1
2.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
375
3628
1.18
0.68
6.5
9.1
ml/min/173m2
90.9
91.7
0.44
325
2954
(3028707) Methadone [Presence] in Urine by Screen method
17
119
1.44
0.68
2.5
2.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
211
1965
1.14
0.67
4.4
6.4
e9/l
0.2
0.2
0.10
200
1776
(1761868) Lipid panel - Serum or Plasma
185
1710
1.14
0.66
2.3
2.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
78
1.55
0.66
1.0
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
75
861
0.85
0.64
1.9
2.5
e6/l
0.1
0.4
2.33
59
636
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
6
103
0.58
0.62
3.8
3.3
mg/l
1.1
1.4
—
6
96
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
30
1.67
0.61
1.4
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
135
1229
1.14
0.61
1.5
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
199
1857
1.13
0.60
2.6
2.7
ug/l
70.9
98.8
2.99
192
1763
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
22
0.00
0.59
0.0
1.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
23
0.00
0.58
0.0
1.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
23
0.00
0.58
0.0
1.0
—
25.6
—
0
23
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
183
0.70
0.56
1.8
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
90
0.55
0.56
1.0
1.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
209
1963
1.12
0.56
4.5
5.8
e9/l
1.9
2.0
0.76
198
1776
(40768804) Tissue Pathology biopsy report
165
1529
1.12
0.56
1.8
1.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
65
1.55
0.56
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
27
214
1.28
0.53
2.7
2.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
120
1310
0.89
0.52
3.5
5.9
mmol/l
1.2
1.2
0.08
112
1218
(40768443) Skin Pathology biopsy report
18
136
1.34
0.50
1.3
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
107
0.65
0.49
2.0
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
46
1.53
0.48
1.1
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
25
310
0.80
0.48
1.4
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
13
177
0.73
0.48
1.7
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
48
412
1.18
0.48
1.5
1.6
nmol/l
1132.8
1188.7
0.22
40
331
(3019060) Gas panel - Arterial blood
20
155
1.30
0.47
2.3
7.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
19
147
1.31
0.46
1.4
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
79
878
0.88
0.46
1.5
1.3
g/l
2.3
2.2
0.17
63
579
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
7
50
1.41
0.45
1.7
1.5
—
10.4
—
0
8
(3037467) Urinalysis macro (dipstick) panel - Urine
263
2521
1.10
0.45
3.3
3.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
398
3899
1.15
0.44
3.9
4.0
mmol/l
3.0
2.9
2.02
381
3708
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
31
1.62
0.43
2.0
1.7
g/l
1.0
1.0
—
5
31
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
17
217
0.78
0.42
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
17
217
0.78
0.42
1.6
1.4
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
32
1.57
0.42
1.4
2.1
mmol/l
105.4
105.4
—
5
32
(3041354) Potassium [Moles/volume] in Venous blood
5
32
1.57
0.42
1.4
2.1
mmol/l
3.9
4.0
—
5
32
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
32
1.57
0.42
1.4
2.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.7
—
16.1
—
0
15
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
26
314
0.82
0.41
1.4
1.7
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
0
16
0.00
0.41
0.0
1.3
—
2925.1
—
0
8
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
303
2931
1.10
0.41
2.7
2.9
u/l
49.7
40.9
0.31
295
2832
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
4.1
—
7.4
—
0
17
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
394
3863
1.13
0.40
3.7
3.7
mmol/l
5.0
4.8
2.00
379
3693
(40768797) Stomach Pathology biopsy report
54
476
1.15
0.40
1.1
1.2
—
—
—
0
0
(4146454)
0
18
0.00
0.40
0.0
3.6
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
35
1.43
0.39
5.0
3.1
u/ml
30.6
47.0
—
5
35
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
334
3249
1.10
0.39
3.4
3.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
19
0.00
0.39
0.0
1.2
—
12.9
—
0
19
(3010421) pH of Blood
9
67
1.35
0.38
1.1
2.5
ph
7.4
7.4
—
9
54
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
12
89
1.36
0.38
1.1
1.3
e6/l
2.3
5.8
0.52
12
69
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
12
89
1.36
0.38
1.2
1.4
e6/l
239.9
150.5
0.19
12
72
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
8
112
0.71
0.37
1.1
1.2
—
3.1
—
0
14
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
107
1.32
0.37
2.1
2.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
8
114
0.70
0.37
1.1
1.2
—
16.4
—
0
20
(3011397) Hemoglobin [Presence] in Urine by Test strip
90
826
1.11
0.37
3.6
2.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
80
730
1.12
0.36
1.3
1.3
iu/ml
27.4
26.5
0.02
27
248
(36304419) Bacteria [Presence] in Urine
80
874
0.90
0.36
2.0
2.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
12
90
1.34
0.36
1.1
1.3
mmol/l
3.7
3.7
0.07
12
82
(3047352) Trisomy 18 risk [Likelihood] in Fetus
14
178
0.78
0.35
1.6
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
41
360
1.15
0.33
1.9
2.1
nmol/l
388.8
374.7
0.12
36
339
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
6
90
0.66
0.33
2.2
2.3
ug/l
160.8
315.3
—
6
83
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
101
940
1.10
0.32
1.7
2.1
u/l
130.9
228.8
0.80
96
892
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
392
3855
1.11
0.32
3.7
3.7
mmol/l
1.5
1.5
0.75
377
3674
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
112
1048
1.09
0.32
1.8
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
96
892
1.10
0.32
1.8
1.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
16
197
0.81
0.31
1.6
2.2
g/l
71.8
68.2
2.68
16
185
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
65
592
1.11
0.31
1.8
2.8
ng/l
683.2
592.2
0.10
56
488
(3026493) Urate [Moles/volume] in Serum or Plasma
93
864
1.10
0.31
1.5
2.2
umol/l
311.5
4640.7
2.45
86
787
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
18
218
0.82
0.31
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
18
218
0.82
0.31
1.6
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
55
1.28
0.30
1.0
2.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
43
384
1.13
0.29
2.2
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
103
1.27
0.28
1.8
1.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
32
280
1.15
0.28
3.4
10.7
mmol/l
0.4
1.2
0.49
11
221
(3013512) EKG study
86
801
1.09
0.27
2.2
2.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
197
1896
1.07
0.27
4.5
5.9
e9/l
0.0
0.0
0.03
188
1686
(3022145) Colonoscopy Study observation
37
414
0.88
0.26
1.4
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
89
950
0.92
0.26
1.9
2.6
e6/l
18.6
64.9
1.73
70
719
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
76
706
1.09
0.26
1.2
1.2
u/ml
15.9
7.7
0.45
43
294
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
75
0.66
0.26
1.0
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
196
1889
1.07
0.26
4.5
5.8
e9/l
0.5
0.5
0.32
188
1682
(3021589) Normoblasts [#/volume] in Blood
161
1678
0.94
0.25
6.8
7.8
e9/l
0.0
0.0
1.16
151
1387
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
36
401
0.89
0.24
1.5
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
81
0.74
0.24
1.2
1.3
—
1.2
—
0
6
(3000492) Spirometry study
48
438
1.11
0.24
1.3
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
55
597
0.91
0.23
2.1
2.2
mosm/kgh2o
534.4
556.0
0.28
42
518
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
136
0.80
0.23
1.6
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
52
565
0.91
0.23
1.9
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
26
294
0.88
0.22
2.2
2.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
14
167
0.83
0.22
1.6
3.3
mmol/l
1.2
1.1
—
9
122
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
31
277
1.13
0.22
1.6
2.3
ml/min/173m2
79.3
75.4
0.27
13
119
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
35
387
0.90
0.21
1.6
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
10
0.00
0.21
0.0
3.4
—
260.6
—
0
10
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
12
0.00
0.21
0.0
3.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
12
0.00
0.21
0.0
3.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
39
428
0.90
0.21
1.5
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
16
187
0.85
0.20
1.4
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
155
0.83
0.20
2.1
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
48
1.25
0.20
1.2
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3024471) HLA-A [Type]
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
113
0.79
0.20
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
113
0.79
0.20
1.3
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
18
155
1.17
0.20
2.3
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
51
1.18
0.19
1.2
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
13
154
0.84
0.19
1.2
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
41
446
0.91
0.19
1.6
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
33
363
0.90
0.19
1.1
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
41
377
1.10
0.18
1.1
1.3
iu/ml
57.3
162.1
3.73
17
158
(3009445) Proteinase 3 Ab [Units/volume] in Serum
13
153
0.85
0.18
1.2
1.5
—
10.1
—
0
5
(3018095) Leukocytes [#/volume] in Urine
113
1178
0.95
0.18
2.2
3.0
e6/l
26.0
85.7
1.24
78
785
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
82
1.22
0.17
1.0
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
15
173
0.86
0.17
1.7
3.2
kpa
5.2
5.1
0.07
15
165
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
343
3384
1.05
0.16
3.9
4.4
mmol/mol
37.0
38.2
2.05
329
3230
(3009343) pH of Capillary blood
15
172
0.87
0.16
1.7
3.2
—
7.4
—
0
19
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
73
768
0.94
0.16
1.9
2.0
mg/l
2.8
2.8
0.03
65
669
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
77
0.78
0.15
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
6
79
0.76
0.15
3.7
1.8
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
10
119
0.84
0.15
1.6
1.7
—
256.0
—
0
5
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
140
0.85
0.15
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
21
188
1.12
0.15
2.0
3.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
136
1317
1.05
0.15
2.9
4.8
g/l
38.1
37.0
1.95
130
1247
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
52
489
1.07
0.15
2.5
2.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
166
1705
0.96
0.14
4.3
5.9
%
0.7
0.7
0.00
161
1610
(3052851) Hemolysis interference index of Serum or Plasma
7
88
0.79
0.14
3.1
2.5
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
7
89
0.78
0.14
1.3
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
72
754
0.95
0.14
2.5
3.4
mg/l
903.0
337.3
0.28
51
499
(40768793) Breast Pathology biopsy report
9
107
0.84
0.13
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
127
0.86
0.12
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
19
172
1.11
0.11
1.3
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
12
105
1.15
0.11
1.2
1.3
ug/l
4.5
2.9
0.51
12
95
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
109
1122
0.96
0.11
2.5
2.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
86
831
1.04
0.10
1.8
2.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
125
0.88
0.10
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
125
0.88
0.10
1.0
1.1
—
—
—
0
0
(4034850)
14
125
1.12
0.10
3.1
7.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
154
1.11
0.10
1.4
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
38
359
1.06
0.10
2.8
3.4
%
29.7
31.5
0.56
31
264
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
54
517
1.05
0.09
1.9
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
186
1828
1.03
0.09
4.1
5.6
%
54.5
56.5
1.95
179
1738
(3021879) Hepatitis B virus core Ab [Presence] in Serum
39
370
1.06
0.09
1.7
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
22
237
0.92
0.09
3.3
3.2
mmol/l
2.2
1.9
0.17
16
189
(3004716) Salmonella sp identified in Stool by Organism specific culture
26
277
0.93
0.08
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
62
0.80
0.08
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
62
0.80
0.08
1.2
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
5
63
0.79
0.08
2.6
2.7
mmol/l
23.7
24.0
—
5
58
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
64
0.78
0.08
1.0
1.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
11
123
0.89
0.08
2.1
3.2
mmol/l
23.8
23.9
—
6
113
(3020682) Albumin/Creatinine [Ratio] in Urine
77
793
0.97
0.08
3.0
4.0
mg/mmol
6.3
11.5
0.48
55
519
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
68
1.03
0.08
1.6
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
221
2182
1.02
0.07
5.8
8.9
e9/l
3.7
3.9
1.45
205
1929
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
74
0.81
0.07
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
137
1.10
0.07
2.0
2.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
147
1.09
0.07
1.6
2.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
78
1.03
0.07
1.1
1.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
187
1844
1.02
0.07
4.3
5.8
%
30.8
29.4
1.17
182
1750
(3050129) First trimester maternal screen panel - Serum or Plasma
27
255
1.06
0.07
1.5
1.4
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
11
122
0.90
0.07
1.1
1.2
—
20.0
—
0
9
(3025130) Human papilloma virus identified in Specimen
9
86
1.05
0.07
1.4
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
91
0.88
0.07
1.1
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
93
0.86
0.07
1.4
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
43
447
0.96
0.06
1.7
2.2
—
—
—
0
0
(3012544) pH of Venous blood
23
244
0.94
0.06
3.2
3.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
13
142
0.91
0.06
3.2
15.3
—
—
—
0
0
(4094501)
9
101
0.89
0.06
1.0
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
107
1091
0.97
0.06
5.1
5.5
inr
1.1
1.1
0.09
35
352
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
109
1.10
0.06
1.5
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
67
688
0.97
0.06
1.8
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
347
3450
1.02
0.05
10.0
12.9
%
13.4
13.5
0.34
341
3402
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
102
1002
1.02
0.05
1.4
1.3
u/ml
0.8
1.6
1.10
40
293
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
150
1482
1.02
0.04
3.7
6.6
mmol/l
1.2
1.2
0.13
131
1265
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
14
150
0.93
0.04
3.5
8.3
mmol/l
22.9
25.0
2.44
14
150
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
21
220
0.95
0.03
1.2
1.8
mg/l
2.0
3.6
1.10
13
152
(3026008) Bacteria identified in Urine by Culture
88
868
1.02
0.03
2.2
2.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
66
649
1.02
0.02
1.8
2.2
e6/l
4.2
7.7
1.54
58
578
(3019069) Monocytes/100 leukocytes in Blood
176
1773
0.99
0.02
4.4
6.1
%
8.4
8.2
0.55
171
1687
(3022217) INR in Platelet poor plasma by Coagulation assay
27
261
1.04
0.02
10.7
12.2
inr
1.0
1.2
—
6
42
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
176
1770
0.99
0.01
4.1
6.1
umol/l
9.7
10.4
0.71
169
1695
(46235355) HIV 1 and 2 tests - Meaningful Use set
111
1119
0.99
0.01
2.1
2.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
23
224
1.03
0.00
1.0
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
49
496
0.99
0.00
1.7
2.2
e6/l
2.1
1.0
0.47
35
259
(3022313) Gas panel - Capillary blood
12
125
0.96
0.00
1.8
3.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
14
135
1.04
0.00
3.2
2.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
13
134
0.97
0.00
1.5
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
24
235
1.02
0.00
1.5
1.5
—
—
—
0
0
(3019225) pH of Specimen
25
255
0.98
0.00
1.9
4.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
26
265
0.98
0.00
1.4
1.3
—
21.9
—
0
11
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
13
127
1.02
0.00
3.4
2.2
%
1.4
1.3
0.08
13
127
(3048929) Epstein Barr virus Ab [Presence] in Serum
17
173
0.98
0.00
1.1
1.3
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
13
128
1.02
0.00
3.8
3.1
mmol/l
26.0
25.2
0.39
13
122
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
25
252
0.99
0.00
1.1
1.0
—
—
—
0
0
(3020891) Body temperature
10
99
1.01
0.00
5.6
4.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
12
119
1.01
0.00
1.8
2.3
%
86.8
92.7
0.55
12
111
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
149
1488
1.00
0.00
1.9
2.3
nmol/l
78.2
73.9
1.21
143
1400
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
136
1361
1.00
0.00
3.3
3.1
u/l
30.4
31.5
0.14
131
1303
(3037522) Nuclear Ab [Titer] in Serum
58
585
0.99
0.00
1.2
1.4
titre
448.0
551.9
—
10
119
(3009542) Hematocrit [Volume Fraction] of Blood
387
3874
0.99
0.00
8.8
11.2
%
40.2
40.7
0.50
309
3227
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
7.1
—
0
7
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
10.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
58
0.86
0.00
1.2
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
80
1.00
0.00
1.5
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
80
1.00
0.00
1.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
7
76
0.92
0.00
1.0
1.1
%
105.7
116.6
—
7
69
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
58
0.86
0.00
2.8
2.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
10.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
8.2
—
0
7
(3042517) Benzodiazepines panel - Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
11.7
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
68
0.88
0.00
1.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
54
0.93
0.00
1.6
3.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
1.7
—
0
8
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
87
0.92
0.00
1.5
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
51
0.98
0.00
1.4
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
65
0.92
0.00
1.3
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
56
0.89
0.00
1.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
3.5
—
0.7
—
0
6
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
21
210
1.00
0.00
1.7
1.6
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
53
0.94
0.00
1.0
1.2
u/l
10.8
11.0
—
5
46
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
79
0.88
0.00
1.6
2.7
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
12.7
—
0
5
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
67
0.89
0.00
1.0
1.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
8
0.00
0.00
0.0
3.9
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
8
0.00
0.00
0.0
8.4
—
25.0
—
0
8
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
10
100
1.00
0.00
1.1
1.2
—
30.2
—
0
10
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(4306422)
7
75
0.93
0.00
1.1
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
0
5
0.00
0.00
0.0
5.6
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
15.1
—
0
5
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
97
0.93
0.00
1.1
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
79
1.01
0.00
1.1
1.4
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
8
0.00
0.00
0.0
1.3
—
129.1
—
0
8
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
8
84
0.95
0.00
1.0
1.1
—
13.7
—
0
9
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint K11_DEEP_BITE_SURGERY and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_DEEP_BITE_SURGERY.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: K11_DEEP_BITE_SURGERY – Deep bite that required surgery

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data